
RTT News
<img alt="" height="1" width="1" />
FDA approves Regeneron's eye injection Eylea
BusinessWeek
Regeneron Pharmaceuticals Inc. says regulators approved marketing of its eye drug Eylea, an injection designed to treat a common cause of blindness in senior citizens. Eylea is intended to treat "wet" age-related macular degeneration. ...
FDA Approves Regeneron's Eylea For Vision-Loss DiseaseWall Street Journal
FDA approves Regeneron's eye injection EyleaThe Associated Press
Macular Degeneration Drug Eylea ApprovedWebMD
New York Times -Reuters
all 151 news articles »
More...